These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15077797)

  • 1. Pathogenesis of a Marek's disease virus mutant lacking vIL-8 in resistant and susceptible chickens.
    Cortes PL; Cardona CJ
    Avian Dis; 2004; 48(1):50-60. PubMed ID: 15077797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype.
    Miles AM; Reddy SM; Morgan RW
    Avian Dis; 2001; 45(1):9-18. PubMed ID: 11332504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain.
    Cui X; Lee LF; Hunt HD; Reed WM; Lupiani B; Reddy SM
    Avian Dis; 2005 Jun; 49(2):199-206. PubMed ID: 16094823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV.
    Parcells MS; Lin SF; Dienglewicz RL; Majerciak V; Robinson DR; Chen HC; Wu Z; Dubyak GR; Brunovskis P; Hunt HD; Lee LF; Kung HJ
    J Virol; 2001 Jun; 75(11):5159-73. PubMed ID: 11333897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus.
    Bertzbach LD; Laparidou M; Härtle S; Etches RJ; Kaspers B; Schusser B; Kaufer BB
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11603-11607. PubMed ID: 30337483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
    Haq K; Fear T; Ibraheem A; Abdul-Careem MF; Sharif S
    Avian Pathol; 2012; 41(1):69-75. PubMed ID: 22845323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very virulent plus strains of MDV induce an acute form of transient paralysis in both susceptible and resistant chicken lines.
    Xu M; Fitzgerald SD; Zhang H; Karcher DM; Heidari M
    Viral Immunol; 2012 Aug; 25(4):306-23. PubMed ID: 22803780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
    Omar AR; Schat KA
    Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency.
    Cui X; Lee LF; Reed WM; Kung HJ; Reddy SM
    J Virol; 2004 May; 78(9):4753-60. PubMed ID: 15078957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system.
    Abdul-Careem MF; Hunter BD; Sarson AJ; Mayameei A; Zhou H; Sharif S
    Viral Immunol; 2006; 19(2):167-76. PubMed ID: 16817759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Route of challenge is critical in determining the clinical outcome of infection with a very virulent oncogenic herpesvirus, Marek's disease virus.
    Butter C; Staines K; Baaten B; Smith L; Davison TF
    Avian Pathol; 2007 Apr; 36(2):93-9. PubMed ID: 17479368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.
    Parcells MS; Anderson AS; Morgan TW
    J Virol; 1995 Dec; 69(12):7888-98. PubMed ID: 7494301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek's disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells.
    Rémy S; Blondeau C; Le Vern Y; Lemesle M; Vautherot JF; Denesvre C
    Vet Res; 2013 Dec; 44(1):125. PubMed ID: 24359464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion.
    Jarosinski KW; Hunt HD; Osterrieder N
    Virology; 2010 Sep; 405(2):457-63. PubMed ID: 20637486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
    Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
    J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.